ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 1 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $32,000 | -37.3% | 189,959 | 0.0% | 0.00% | – |
Q2 2022 | $51,000 | -51.9% | 189,959 | 0.0% | 0.00% | – |
Q1 2022 | $106,000 | -16.5% | 189,959 | +4.4% | 0.00% | – |
Q4 2021 | $127,000 | -59.9% | 182,003 | -6.4% | 0.00% | – |
Q3 2021 | $317,000 | -15.9% | 194,403 | +2.7% | 0.00% | – |
Q2 2021 | $377,000 | -74.1% | 189,203 | -56.8% | 0.00% | – |
Q1 2021 | $1,453,000 | -18.6% | 437,719 | -2.4% | 0.00% | – |
Q4 2020 | $1,784,000 | +52.3% | 448,291 | +0.7% | 0.00% | – |
Q3 2020 | $1,171,000 | -10.8% | 445,336 | +2.8% | 0.00% | – |
Q2 2020 | $1,313,000 | +59.0% | 433,363 | +2.8% | 0.00% | – |
Q1 2020 | $826,000 | -73.3% | 421,370 | +0.4% | 0.00% | – |
Q4 2019 | $3,089,000 | +79.2% | 419,738 | +10.0% | 0.00% | – |
Q3 2019 | $1,724,000 | -54.4% | 381,493 | +0.5% | 0.00% | – |
Q2 2019 | $3,783,000 | -10.2% | 379,466 | +5.2% | 0.00% | – |
Q1 2019 | $4,213,000 | +1.3% | 360,685 | +4.2% | 0.00% | – |
Q4 2018 | $4,159,000 | -29.1% | 346,308 | +0.7% | 0.00% | – |
Q3 2018 | $5,863,000 | +4.5% | 343,859 | +4.6% | 0.00% | – |
Q2 2018 | $5,610,000 | – | 328,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|